Papia Basuthakur

Papia Basuthakur

Auto-generated profile, based on publicly available information

Papia Basuthakur

Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2019 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
ABAyan Kumar Barui
Ayan Kumar Barui
SNSusheel Kumar Nethi
Susheel Kumar Nethi
SHShagufta Haque
Shagufta Haque
PBPapia Basuthakur
Papia Basuthakur
CPChittaranjan Patra
Chittaranjan Patra

24 August 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
ZXZhiyang Xu
Zhiyang Xu
YXYulong Xu
Yulong Xu
PBPapia Basuthakur
Papia Basuthakur
CPChittaranjan Patra
Chittaranjan Patra
Seeram RamakrishnaSeeram Ramakrishna
Seeram Ramakrishna
Himansu Sekhar NandaHimansu Sekhar Nanda
Himansu Sekhar Nanda
Functionalized cerium oxide nanoparticle (CeNP)-loaded fibro-porous poly-L-lactic acid (PLLA)/gelatin composite membranes were prepared via an electrospinning technology. Considering the importance of such membrane scaffolds for promoting angiogenesis in tissue engineering and drug screening, a series of PLLA/gelatin composite fiber membranes loaded with different doses of CeNPs was prepared. The prepared composite membranes demonstrated hydrophilicity, water absorption, and improved mechanical properties compared to a PLLA and PLLA/gelatin membrane. Also, cell viability assay using somatic hybrid endothelial cells (EA.hy926) proved the biocompatible nature of the scaffolds. The biocompatibility was further supported by in vivo chick embryo angiogenesis assay using fertilized eggs. Our initial results support that these membrane scaffolds could be useful for angiogenesis-related disease treatment after further investigations.

26 March 2021 in Biomedical Materials
Verified
Journal Article
Closed access
PDF file
ABAyan Kumar Barui
Ayan Kumar Barui
SNSusheel Kumar Nethi
Susheel Kumar Nethi
PBPapia Basuthakur
Papia Basuthakur
PJPriya Jhelum
Priya Jhelum
VBVishnu Sravan Bollu
Vishnu Sravan Bollu
CPChittaranjan Patra
Chittaranjan Patra
Critical limb ischemia (CLI) is a severe type of peripheral artery disease (PAD) which occurs due to an inadequate supply of blood to the limb extremities. Patients with CLI often suffer from extreme cramping pain, impaired wound healing, immobility, cardiovascular complications, amputation of the affected limb and even death. The conventional therapy for treating CLI includes surgical revascularization as well as restoration of angiogenesis using growth factor therapy. However, surgical revascularization is only suitable for a small percentage of CLI patients and is associated with a high perioperative mortality rate. The use of growth factors is also limited in terms of their poor therapeutic angiogenic potential, as observed in earlier clinical studies which could be attributed to their poor bio-availability and non-specificity issues. Therefore, to overcome the aforesaid disadvantages of conventional strategies there is an urgent need for the advancement of new alternative therapeutic biomaterials to treat CLI. In the past few decades, various research groups, including ours, have been involved in developing different pro-angiogenic nanomaterials. Among these, zinc oxide nanoflowers (ZONFs), established in our laboratory, are considered one of the more potent nanoparticles for inducing therapeutic angiogenesis. In our earlier studies we showed that ZONFs promote angiogenesis by inducing the formation of reactive oxygen species and nitric oxide (NO) as well as activating Akt/MAPK/eNOS cell signaling pathways in endothelial cells. Recently, we have also reported the therapeutic potential of ZONFs to treat cerebral ischemia through their neuritogenic and neuroprotective properties, exploiting angio-neural cross-talk. Considering the excellent pro-angiogenic properties of ZONFs and the importance of revascularization for the treatment of CLI, in the present study we comprehensively explore the therapeutic potential of ZONFs in a rat hind limb ischemia model (established by ligating the hind limb femoral artery), an animal model that mimics CLI in humans. The behavioral studies, laser Doppler perfusion imaging, histopathology and immunofluorescence as well as estimation of serum NO level showed that the administration of ZONFs could ameliorate ischemia in rats at a faster rate by promoting therapeutic angiogenesis to the ischemic sites. Altogether, the present study offers an alternative nanomedicine approach employing ZONFs for the treatment of PADs.

7 June 2024 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
PBPapia Basuthakur
Papia Basuthakur
ARArpita Roy
Arpita Roy
SGSoumya Ghosh
Soumya Ghosh
VVVincy Vijay
Vincy Vijay
DSDebiprasad Sinha
Debiprasad Sinha
SCSumana Chakravarty
Sumana Chakravarty

20 October 2020 in Nanomedicine
Verified
Journal Article
Closed access
PBPapia Basuthakur
Papia Basuthakur
CPChittaranjan Patra
Chittaranjan Patra